BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22616110)

  • 1. Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.
    Hinton DJ; Lee MR; Jacobson TL; Mishra PK; Frye MA; Mrazek DA; Macura SI; Choi DS
    Neuropharmacology; 2012 Jun; 62(8):2480-8. PubMed ID: 22616110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1.
    Lee MR; Hinton DJ; Wu J; Mishra PK; Port JD; Macura SI; Choi DS
    Neurosci Lett; 2011 Feb; 490(2):90-5. PubMed ID: 21172405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling.
    Nam HW; Lee MR; Zhu Y; Wu J; Hinton DJ; Choi S; Kim T; Hammack N; Yin JC; Choi DS
    Biol Psychiatry; 2011 Jun; 69(11):1043-51. PubMed ID: 21489406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal Model.
    Germany CE; Reker AN; Hinton DJ; Oliveros A; Shen X; Andres-Beck LG; Wininger KM; Trutschl M; Cvek U; Choi DS; Nam HW
    Proteomics; 2018 Apr; 18(7):e1700417. PubMed ID: 29437267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acamprosate decreases the hypermotility during repeated ethanol withdrawal.
    Dahchour A; De Witte P
    Alcohol; 1999 May; 18(1):77-81. PubMed ID: 10386669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binge ethanol withdrawal: Effects on post-withdrawal ethanol intake, glutamate-glutamine cycle and monoamine tissue content in P rat model.
    Das SC; Althobaiti YS; Alshehri FS; Sari Y
    Behav Brain Res; 2016 Apr; 303():120-5. PubMed ID: 26821293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1.
    Nam HW; Lee MR; Hinton DJ; Choi DS
    Neurosci Lett; 2010 Aug; 479(3):277-81. PubMed ID: 20570605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats.
    Dahchour A; De Witte P; Bolo N; Nédélec JF; Muzet M; Durbin P; Macher JP
    Psychiatry Res; 1998 May; 82(2):107-14. PubMed ID: 9754453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers.
    Bolo N; Nédélec JF; Muzet M; De Witte P; Dahchour A; Durbin P; Macher JP
    Psychiatry Res; 1998 May; 82(2):115-27. PubMed ID: 9754454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurine blocks the glutamate increase in the nucleus accumbens microdialysate of ethanol-dependent rats.
    Dahchour A; De Witte P
    Pharmacol Biochem Behav; 2000 Feb; 65(2):345-50. PubMed ID: 10672989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1.
    Chen J; Nam HW; Lee MR; Hinton DJ; Choi S; Kim T; Kawamura T; Janak PH; Choi DS
    Behav Brain Res; 2010 Apr; 208(2):636-42. PubMed ID: 20085785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal.
    Putzke J; Spanagel R; Tölle TR; Zieglgänsberger W
    Eur J Pharmacol; 1996 Dec; 317(1):39-48. PubMed ID: 8982717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour.
    Gewiss M; Heidbreder C; Opsomer L; Durbin P; De Witte P
    Alcohol Alcohol; 1991; 26(2):129-37. PubMed ID: 1652250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference.
    Choi DS; Cascini MG; Mailliard W; Young H; Paredes P; McMahon T; Diamond I; Bonci A; Messing RO
    Nat Neurosci; 2004 Aug; 7(8):855-61. PubMed ID: 15258586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.
    Dahchour A; De Witte P
    Alcohol Clin Exp Res; 2003 Mar; 27(3):465-70. PubMed ID: 12658112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum.
    Hinton DJ; Lee MR; Jang JS; Choi DS
    Brain Behav; 2014; 4(6):903-14. PubMed ID: 25365803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 equilibrative nucleoside transporter (ENT1) regulates sex-specific ethanol drinking during disruption of circadian rhythms.
    Jia YF; Vadnie CA; Ho AM; Peyton L; Veldic M; Wininger K; Matveyenko A; Choi DS
    Addict Biol; 2020 Sep; 25(5):e12801. PubMed ID: 31267611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acamprosate on attentional set-shifting and cellular function in the prefrontal cortex of chronic alcohol-exposed mice.
    Hu W; Morris B; Carrasco A; Kroener S
    Alcohol Clin Exp Res; 2015 Jun; 39(6):953-61. PubMed ID: 25903298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes.
    Wu J; Lee MR; Choi S; Kim T; Choi DS
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1110-7. PubMed ID: 20374202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat.
    Spanagel R; Putzke J; Stefferl A; Schöbitz B; Zieglgänsberger W
    Eur J Pharmacol; 1996 Jun; 305(1-3):45-50. PubMed ID: 8813530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.